The highly potent antitumor agent ansamitocin P3 is a macrolactam isolated from Actinosynnema pretiosum ATCC 31565. A 120-kb DNA fragment was previously identified as the ansamitocin biosynthetic gene cluster, and contains genes for polyketide assembly, precursor synthesis, post-polyketide synthesis modification, and regulation. Within the biosynthetic gene cluster, asm8 encodes an 1117-amino-acid protein with a high degree of similarity to the large ATP-binding LuxR family-type regulators. In the current study, we determined that inactivation of asm8 by gene replacement in ATCC 31565 resulted in the complete loss of ansamitocin production, and that complementation with a cloned asm8 gene restored ansamitocin biosynthesis. Interestingly, the disruption of asm8 decreased the transcription of genes responsible for 3-amino-5-hydroxybenzoate (AHBA) formation, the starter unit required for ansamitocin biosynthesis. Subsequently, feeding of exogenous AHBA to the asm8 mutant restored ansamitocin biosynthesis, which showed that Asm8 is a specific positive regulator in AHBA biosynthesis. In addition, investigation of asm8 homologs identified two new ansamitocin producers, and inactivation of the asm8 homolog in A. pretiosum ATCC 31280 abolished ansamitocin production in this strain. Characterization of the positive regulator Asm8 and discovery of the two new ansamitocin producers paves the way for further improving production of this important antitumor agent.
Like their plant-derived maytansinoid counterparts [1] , ansamitocins (e.g., ansamitocin P-3; AP-3) demonstrate potent antitumor activity by specifically inhibiting eukaryotic mitosis [2] . The antibody-conjugated drug Kadcyla uses maytansinoid as the active compound, and was approved in February 2013 by the United States Food and Drug Administration for treating breast cancer [3] . Produced by Actinosynnema pretiosum subsp. auranticum ATCC 31565 (hereafter referred to as ATCC 31565), these microbial metabolites belong to an important class of polyketide natural products called ansamycins [2] . All ansamycin antibiotics are macrolactams, and are characterized by an amide-linkageterminated benzoic acid or a naphthalenic chromophore bridged by an aliphatic polyketide. Typical ansamycins include rifamycin, ansamitocin, and macbecins.
Biosynthesis of ansamycin antibiotics involves the formation of 3-amino-5-hydroxybenzoate (AHBA) as the starter unit for the assembly of the polyketide chain. The first three steps of the AHBA pathway are very similar to the shikimate pathway, but later steps are differentiated by the introduction of glutamine-derived nitrogen, to give 3,4-dideoxy-4-amino-D-arabino-heptulosonic acid 7-phosphate (aminoDAHP). Cyclization and dehydration of amino-DAHP generates 5-deoxy-5-amino-3-dehydroquinic acid (aminoDHS), which is finally aromatized by the enzyme AHBA synthase to give AHBA [4, 5] . Sequence analysis of the ansamitocin biosynthetic gene cluster identified 52 open reading frames in two separate regions of 83 and 12 kb [6] . Among these genes, asm47, -23, -44, -45, and -22 are homologs of rifG, -J, -L, -M, and -N, respectively, from the rifamycin biosynthetic gene cluster [6] . Both asm24 and asm43 are homologs of rifK [5] (Figure 1A) . Moreover, genes asm43-47 form an operon, and asm23 and 24 are transcribed from a divergent promoter region ( Figure 1B) .
The biosynthetic mechanism of ansamitocins has been studied extensively [6] [7] [8] [9] . However, little is known about the regulation of ansamitocin biosynthesis. Previous sequencing of the ansamitocin biosynthetic gene cluster has revealed the presence of a set of regulatory genes. Three genes, asm2, -29, and -34, encode TetR family proteins, while asm31, -39, and -40 encode a sigma factor, sigma factor antagonist, and anti-sigma antagonist, respectively. The protein encoded by asm18 is homologous to a SARP (Streptomyces antibiotic regulatory protein) family protein.
The remaining two proteins, encoded by asm8 and asm48, are similar to LuxR or LAL family (large ATP-binding regulator of the LuxR family) regulatory proteins.
A previous study showed that in-frame deletion of asm2 caused an over-production of ansamitocins [10] . More interestingly, AP-3 production was also increased by constitutive over-expression of asm2 and asm39 [11] .
Here, the function of asm8 was studied through gene inactivation, complementation, transcriptional analysis, and feeding experiments. Results showed that asm8 is a positive regulator of ansamitocin production, specifically the formation of the AHBA starter unit, in ATCC 31565. Further investigation of asm8 homologs through gene comparison and gene inactivation identified two additional novel ansamitocin producers.
1 Materials and methods
Bacterial strains, cloning vectors, and cultivation
Strains and plasmids used in this study are listed in Table  S1 . in E. coli. Shuttle vectors pIB139 [14] and pSET152 [15] were used for gene complementation.
Genetic manipulation
Standard genetic techniques using E. coli and in vitro DNA manipulation were performed as described by Sambrook et al. [16] . Recombinant DNA techniques in Actinosynnema species and isolation of Actinosynnema DNA were performed as described previously [17] .
Disruption of asm8 using Redirect Technology
A 7.0-kb Sac I/BamH I fragment from cosmid 3C11 [6] was cloned into pJTU1278, to generate pJTU851. The 3.40-kb asm8 gene within pJTU851 was replaced with an aac3(IV)-oriT cassette, to generate pJTU852, using Redirect Technology according to a previously published method [18] . The aac(3)IV-oriT cassette was amplified from pIJ773 using primer pair asm8-tgt-F (5′-ATGCGGCTGGTGGACCGCGACGGGCAGTGCGAGGCGCTGattccggggatccgtcgacc-3′) and asm8-tgt-R (5′-TCAGGCGGGGGTGGTCAGGTCGGCGTGCAGGGTGGTGGGtgtaggctggagctgcttc-3′) (pIJ773 homologous sequences are in lowercase). For a marker-free gene replacement, pJTU852 was digested with Xba I and then re-ligated to generate pJTU886, in which the aac(3)IV-oriT cassette was replaced with an 81-bp "scar" sequence. pJTU886 was used in conjugation with an apramycin-resistant asm8 mutant to generate the marker-free mutant PW1, which was verified by PCR amplification with the primers asm8-Det-F (5′-AGTGGGGGTGCGGTGGT-3′) and asm8-Det-R (5′-CTGGTCGGGTCGGGGTC-3′).
Trans-complementation of the mutant PW1 with cloned asm8
For the complementation of the PW1 Δasm8 mutant, a 3.80-kb Nru I fragment from pJTU851, containing asm8 and its promoter region, was cloned into pSET152. The resulting plasmid, pJTU3101, was then transferred by conjugation from E. coli ET12567 (pUZ8002) to PW1, as described previously [19] .
Fermentation, purification, and analysis of ansamitocins
Seven-day YMG agar plate cultures of the wild-type ATCC 31565 strain and the PW1 mutant were extracted with ethyl acetate. The extract was concentrated under reduced pressure, and was further extracted with 1 mL methanol. The methanol extract was analyzed by liquid chromatography-mass spectrometry (LC-MS) using an Agilent 1100 series LC/MSD Trap system [8] . High performance liquid chromatography (HPLC) was operated at a flow rate of 0.45 mL min 1 with methanol-water (70/30, v/v) on a Calesil ODS-100 (4.6 mm×150 mm, 5 μm) column. An ion-trap mass spectrometer was operated with the electrospray ionization source in positive ion mode. The drying gas flow was 6 L min 1 , and the nebulizer pressure was 30 psi. The drying gas temperature was 325°C.
RNA isolation and quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis
A two-day culture of A. pretiosum mycelia was collected from YMG agar plates and disrupted using glass beads (150-212 m, Sigma) in a Precellys homogenizer (6500 r min
1
, 2×20 s; Peqlab). RNA was isolated using a Total RNA Isolation Kit (SBS Genetech, Shanghai) and then treated with RNase-free DNase I (Thermo Fisher Scientific Inc.) to eliminate possible chromosomal DNA contamination.
Equal amounts of purified RNA (3 g) were used to generate cDNA using RevertAid H Minus reverse transcriptase and random hexamer primers, as described by the manufacturer (Thermo Fisher Scientific Inc.). The conditions were as follows: first strand cDNA synthesis, 42°C for 1 h, followed by 70°C for 10 min. One microliter of synthesized cDNA was then used as template for each qRT-PCR, which was performed following the Maxima SYBR Green/ROX qPCR master mix protocol (Thermo Fisher Scientific Inc.). The conditions were as follows: 50°C for 20 s, 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. The DNA gyrase gene gyrB was used as an internal control. The transcription of 45 genes in the biosynthetic gene cluster was analyzed.
Results

Asm8 is positively involved in ansamitocin biosynthesis
To investigate the function of asm8, an in-frame deletion of asm8 was performed in E. coli using Redirect Technology [18] , followed by two rounds of conjugation with ATCC 31565 (Figure 2A ). Three thiostrepton-sensitive apramycinsensitive (Thio S Apr S ) mutants (designated PW1-1-PW1-3) were obtained. Total genomic DNA was extracted from the mutants and the wild-type was compared by PCR. The wild-type gave a 3.80-kb amplified product, whereas amplicons from the mutants were only 0.60 kb ( Figure 2B ), confirming that a 3354-bp internal DNA fragment, corresponding to asm8, had been replaced by an 81-bp scar fragment in the mutant genomes. ATCC 31565 and the PW1 mutants were incubated in fermentation medium for 7 d. The fermentation broths were then analyzed by LC-MS. AP-3, with a retention time of 19.7 min and an m/z of 635, was not detected in the fermentation broths of the PW1 mutants ( Figure 2C ).
To verify that the loss of AP-3 was caused only by the asm8 inactivation, mutant PW1 was trans-complemented with a cloned 3.80-kb DNA fragment containing asm8 and its 280-bp upstream region. Plasmid pJTU3101, carrying the 3.80-kb fragment, was introduced into PW1 by conjugation. AP-3 productivity in the complemented mutant strain was restored to 30% of the wild-type (ATCC 31565) level ( Figure 2C ). The successful trans-complementation of PW1 verified that asm8 is a pathway-specific activator of ansamitocin biosynthesis, and that the upstream 280-bp region of asm8 contains the native promoter in ATCC 31565.
Severely reduced transcription of AHBA biosynthetic genes in PW1
The effect of asm8 mutation on ansamitocin production was further analyzed at the transcription level by qRT-PCR. The 45 genes putatively related to ansamitocin biosynthesis were chosen for transcription analysis. Total RNA from two-day cultures of the wild-type and PW1 mutant were extracted and analyzed by qRT-PCR. Surprisingly, the transcription levels of asm23, -24, -43, -44, -45, -46, and -47 were severely reduced in PW1, whereas transcription levels of the genes responsible for polyketide assembly, methoxymalonyl-ACP biosynthesis, post-PKS modification, and regulation were not affected. Other than asm46, the genes showing reduced expression in PW1 are all involved in AHBA biosynthesis [20] (Figure 3 ). In addition, disruption of asm46 had no effect on AP-3 production (data not shown).
Feeding with AHBA restored ansamitocin biosynthesis
The qRT-PCR analysis suggested that Asm8 specifically regulates the expression of the AHBA biosynthetic genes, rather than acting on the transcription of other biosynthetic genes. More supporting evidence was obtained from feeding experiments, whereby exogenous AHBA was fed to cultures of the PW1 mutant strain. PW1 was cultivated in fermentation medium supplemented with 1, 10, or 20 mg L 1 AHBA.
As shown in Figure 4 , the production level of AP-3 in PW1 gradually increased in proportion to the amount of exogenous AHBA added to the fermentation broths.
Identification of asm8 homologs and two new ansamitocin producers
BLAST analysis of Asm8 against the database identified homologous protein Amir_3178 in Actinosynnema mirum DSM 43827, which had an identity of 77%. As the genome sequence of DSM 43827 is available [21] , the flanking sequences of asm8 and amir_3178 were compared. A strikingly high level of sequence similarity and organization, especially for the ansamitocin biosynthetic genes, was observed between ATCC 31565 and DSM 43827 ( Figure S1 in Supporting Information). Moreover, genes homologous to the AHBA-specific genes asm43-47 were also identified, not only in DSM 43827, but also in A. pretiosum ATCC 31280 [22] , a strain known for ansamycin-type macbecin production ( Figure S1 ). This gene organization suggested that the ansamitocin biosynthetic gene cluster may be present in the ATCC 31280 genome. Several pairs of primers specific for the ansamitocin biosynthetic genes were used to try and PCR amplify the corresponding genes from ATCC 31280. The resultant products were sequenced and found to be identical to the homologous genes in ATCC 31565 (data not shown). In addition, all the three Actinosynnema strains were cultivated on YMG agar plates for 7 d, and the plates were then extracted with ethyl acetate for LC-MS analysis. Interestingly, peaks with the same retention time and mass as AP-3 were detected in both ATCC 31280 and DSM 43827 ( Figure 5A ), confirming the identification of two new ansamitocin- , an amir_3178(31280) mutant, an amir_3178(31280) mutant complemented with cloned asm8, and an amir_3178(31280) mutant supplemented with exogenous AHBA. Gene amir_3178(31280) was homologous to asm8 from ATCC 31280. C, AP-3 production in DSM 43827 and the amir_3178 mutants. Gene amir_3178 is homologous to asm8 from DSM 43827. producing strains.
Inactivation of genes homologous to asm8 in ATCC 31280 and DSM 43827
In strain ATCC 31280, a gene homologous to asm8 was also identical to amir_3178 from DSM 43827, and was subsequently named amir_3178(31280). Gene amir_3178 (31280) was inactivated by gene replacement in ATCC31280 (Figure S2) , and the production of AP-3 was completely abolished ( Figure 5B) . As expected, feeding with exogenous AHBA recovered the AP-3 productivity of the amir_3178(31280) mutant. A trans-complemented mutant with cloned asm8 expressed from plasmid pJTU3101 had restored AP-3 productivity.
Similar gene inactivation of asm8 homologous gene amir_3178 was also performed in DSM 43827 ( Figure S3 ). Even though amir_3178 from DSM 43827 was identical to amir_3178(31280), the amir_3178 deletion mutant was surprisingly found to be capable of producing AP-3, albeit with a reduced yield of 60%-70% of the wild-type level ( Figure 5C ).
Discussion
The LAL family regulatory proteins are characterized by a LuxR-type pattern, consisting of a helix-turn-helix DNAbinding motif (~65 amino acids) at the C terminus, and a distinctive P-loop at the N-terminus, which is specific for an ATP-binding site. With a size of up to 116 kD, Asm8 fits the profile of LAL family proteins, and has a high degree of sequence similarity to a number of Streptomyces regulators, such as GdmRII from S. hygroscopicus 17997 [23] , and AveR from S. avermitilis K139 [24] , which are pathwayspecific transcriptional activators of geldanamycin biosynthesis and avermectin biosynthesis, respectively.
Our experiments demonstrated for the first time that the transcriptional activator gene asm8 is required for AP-3 production, and specifically controls the biosynthesis of the AHBA starter unit. Although most of the antibiotic biosynthetic gene clusters from actinomycetes have one or more regulatory genes [25] , the presence of regulators controlling a complete set of genes with designated functions, such as precursor biosynthesis genes, is rare. Lechner et al. [26] identified a LuxR regulatory gene, salR2, in the salinosporamide biosynthetic gene cluster from Salinispora tropica; this gene is specifically involved in the formation of the halogenated precursor chloroethylmalonylCoA. When the salR2 mutant was supplemented with intermediate 4-chlorocrotonic acid, the productivity of salinosporamide was restored. In the clavulanic acid biosynthetic gene cluster, a LysR transcriptional regulator, ClaR, was specific for the expression of genes in the downstream steps of clavulanic acid production, i.e., in the conversion of clavaminic acid to clavulanic acid [27] .
Transcriptional analysis using qRT-PCR determined that the transcription of seven genes was significantly reduced (Figure 3) , six of which were implicated in AHBA biosynthesis ( Figure 1A) . asm46 was not related to ansamitocin biosynthesis (data not shown). Moreover, the transcription of asm22, encoding a putative kinase and homologous to rifN, was not affected. Even though homologs of asm22 are present in all identified AHBA biosynthetic gene sets [28] , its involvement in AHBA formation in ATCC 31565 needs to be further confirmed, either through gene inactivation or by in vitro enzymatic catalysis with the substrate kanosamine.
To date, the negative regulatory gene asm2 and the positive regulatory gene asm8 are the only two genes characterized among the nine putative regulatory genes within the previously sequenced region [6] . Recently, eight more regulatory genes were identified by sequencing the 30-kb region between Cluster I and Cluster II (GenBank accession number of HQ441578) ( Figure S1 ). The AP-3 yield was nearly doubled in a mutant with the 30-kb region deleted (data not shown). Because there are 18 regulatory genes within the 120-kb ansamitocin biosynthetic gene cluster, the biosynthesis of ansamitocin is assumed to be stringently regulated, which might cause difficulties for increasing the titer of ansamitocin.
Further investigation into the functions of other regulatory genes will assist with boosting the expression of ansamitocin biosynthetic genes, and ultimately increasing the titer. Already, introducing the cloned asm8 plasmid construct into the wild-type ATCC 31565 strain has been shown to increase the AP-3 titer. Moreover, the identification of ATCC 31280 and DSM 43827 as new ansamitocin producers may provide better starting candidates for genetic manipulation and titer improvement.
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